{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:sodium-acetate-injection",
  "slug": "sodium-acetate-injection",
  "title": "FDA shortage status: Sodium Acetate Injection",
  "ingredient": "Sodium Acetate Injection",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "SODIUM ACETATE",
    "SODIUM ACETATE ANHYDROUS"
  ],
  "therapeutic_categories": [
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Pediatric",
    "Total Parenteral Nutrition"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "package_count": 15,
  "packages": [
    {
      "package_ndc": "63323-032-00",
      "product_ndc": "63323-032",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6262-01",
      "product_ndc": "0641-6262",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0641-6261-01",
      "product_ndc": "0641-6261",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3299-05",
      "product_ndc": "0409-3299",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3299-26",
      "product_ndc": "0409-3299",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3299-06",
      "product_ndc": "0409-3299",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3299-25",
      "product_ndc": "0409-3299",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-7299-25",
      "product_ndc": "0409-7299",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-7299-73",
      "product_ndc": "0409-7299",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71357-007-10",
      "product_ndc": "71357-007",
      "company_name": "Milla Pharmaceuticals",
      "manufacturer_name": "MILLA PHARMACEUTICALS INC.",
      "presentation": "Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/15/2026",
      "initial_posting_date": "03/23/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71357-008-10",
      "product_ndc": "71357-007",
      "company_name": "Milla Pharmaceuticals",
      "manufacturer_name": "MILLA PHARMACEUTICALS INC.",
      "presentation": "Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/15/2026",
      "initial_posting_date": "03/23/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71357-002-10",
      "product_ndc": "71357-002",
      "company_name": "Milla Pharmaceuticals",
      "manufacturer_name": "MILLA PHARMACEUTICALS INC.",
      "presentation": "Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/15/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71357-009-10",
      "product_ndc": "71357-007",
      "company_name": "Milla Pharmaceuticals",
      "manufacturer_name": "MILLA PHARMACEUTICALS INC.",
      "presentation": "Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/15/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-047-25",
      "product_ndc": "70069-047",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-048-20",
      "product_ndc": "70069-047",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "02/03/2016",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 13,
    "Limited Availability": 2
  },
  "initial_posting_date": "02/03/2016",
  "latest_source_update": "08/15/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}